It is interesting that the numbers of circulating CD14+highCD16−, CD14+highCD16+ and CD14+lowCD16+ monocytes are also higher in patients with RA who do not respond to adalimumab plus MTX treatment [15]. Here, CD14 is linked to rheumatoid arthritis.